Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FuelCell Energy Inc (FCEL) vs Novavax Inc (NVAX) Price & Performance

FuelCell Energy IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

FuelCell Energy Inc vs Novavax Inc — how do they compare? FuelCell Energy Inc trades at $17.09 (market cap $1.62B), while Novavax Inc trades at $8.19 (market cap $1.39B). The key difference: FuelCell Energy Inc is the larger of the two by market cap. Which is the better fit depends on your goals.

FCELNVAX
Market Cap
$1.62B$1.39B
Sector
IndustrialsHealth
52-Week High
$36.01$11.19
52-Week Low
$3.92$6.22
Enterprise Value
$1.47B$890.94M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FuelCell Energy Inc

FuelCell Energy (FCEL) trades at $17.35, down 18.74% over 24 hours, reflecting recent volatility. The stock shows a bearish technical signal with support at $17 and resistance at $21. Fundamentally, the company reported a net loss of $187.90 million on $158.16 million revenue in 2025, with negative profit margins persisting. Recent news highlights a partnership with Siemens for scalable fuel cell solutions and a $225 million stock offering that caused dilution concerns. Analyst consensus is mixed with a $20.75 price target.

FCEL presents high-risk growth potential driven by AI data center energy demand and strategic partnerships, but faces significant challenges including consistent losses, cash burn, and shareholder dilution. The stock's outlook hinges on execution of commercial projects and path to profitability, with substantial downside risk if growth catalysts fail to materialize.

Novavax Inc

Novavax (NVAX) trades at $8.21, down 2.49% amid bearish technical signals and negative cash flow trends. The company shows mixed fundamentals with strong revenue growth to $1.12B in 2025 and three consecutive earnings beats, but faces profitability challenges with negative net income margin and ROE. Recent news highlights shareholder dissent and underperformance versus broader market trends, while analyst consensus remains bullish with a $14 price target representing 70% upside potential.

The outlook balances significant upside potential against substantial execution risks. Positive catalysts include consistent earnings beats and strong analyst support, but concerns persist around cash burn, negative equity, and competitive vaccine market pressures. Investors face volatility from operational challenges despite attractive valuation multiples.

Returns comparison

Trailing returns across standard periods

About FuelCell Energy Inc

FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.

Read more on FCEL

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX